Skip to content

Glucose meter Usage and Impact in Daily lifE – Diabetes Mellitus

Glucose meter Usage and Impact in Daily lifE – Diabetes Mellitus - GUIDE-DM

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00037145
Enrollment
100
Registered
2025-06-06
Start date
2025-06-30
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E10-E14

Interventions

Group 1: Adult diabetes patients who use a continuous glucose monitoring device (RTCGM) as part of their diabetes management / as well as their health care professionals. There is no intervention, bu

Sponsors

Universitätsklinikum Carl Gustav Carus
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Adults aged 18 years or older - Individuals using a RTCGM as part of their diabetes management - Access to the internet and a compatible smartphone or computer - Commitment to answer online questionnaires - Ability to provide signed informed consent

Exclusion criteria

Exclusion criteria: - Employees any institution involved in conducting, organizing, or financing the study

Design outcomes

Primary

MeasureTime frame
Patient self-management, assessed with the Summary of Diabetes Self-Care Activities Assessment Tool (SDSCA-G) after 3 months

Secondary

MeasureTime frame
Qualitative Endpoints - Handling and evaluation of the blood glucose meter by users and, if applicable, prescribers (treating physicians) - Fulfilment of the expectations of the blood glucose meter by users and, if applicable, prescribers (treating physicians) Quantitative Endpoints - Control of blood glucose levels, expressed as average change in HbA1c (in %) after 3 months - Quality of life, assessed with the questionnaire on problem areas in diabetes (10Q PAID) after 3 months

Countries

Germany

Contacts

Public ContactPeter Schwarz

Carl Gustav Carus Universitätsklinikum, Technische Universität Dresden

peter.schwarz@ukdd.de+493514582715

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026